UPDATE : Monday, September 24, 2018
상단여백
Myungmoon Pharm’s valsartan additionally suspended
The government said it has completed testing all valsartan-using hypertensi...
by Lee Hye-seon  |  2018-08-23 15:10
라인
Ulsan University Hospital professors find acute leukemia therapy candidate
Korean researchers have found a new drug candidate that maximizes the effec...
by Marian Chu  |  2018-08-23 15:09
라인
3 multinationals refuse to take pharma group’s anti-corruption system
GSK Korea, Janssen Korea and Astellas Pharma Korea refused to adopt ISO 370...
by Nam Doo-hyun  |  2018-08-23 12:01
라인
Dong-A ST, Takara Bio signs licensing agreement for oncolytic virus therapy
Dong-A ST said Thursday it signed a development and sales licensing agreeme...
by Marian Chu  |  2018-08-23 11:49
라인
Bridge Biotherapeutics presents preclinical trial results on ATX inhibitor
Bridge Biotherapeutics, also known as BridgeBio, said Thursday it presented...
by Marian Chu  |  2018-08-23 10:31
라인
5 Korean biopharmaceuticals most active in P3 trials in 5 years
More and more Korean pharmaceuticals are jumping into developing new drugs,...
by Marian Chu  |  2018-08-23 10:31
라인
Boramae Hospital develops new method that can detect Parkinson’s
Researchers at Seoul National University Boramae Hospital demonstrated for ...
by Lee Han-soo  |  2018-08-22 15:03
라인
‘N. Korean defectors’ flu vaccination low due to poor health literacy’
North Korean defectors living in South Korea have low levels of influenza v...
by Choi Gwang-seok  |  2018-08-22 14:59
라인
Foreign CEOs to lead Korean units of Novartis, Galderma
Novartis Korea and Galderma Korea will have new foreign CEOs next month.Nov...
by Nam Doo-hyun  |  2018-08-22 13:56
라인
Boehringer Ingelheim to present sub-analyses on Pradaxa at ESC Congress 2018
Boehringer Ingelheim Korea said Wednesday it would present nine sub-analyse...
by Marian Chu  |  2018-08-22 12:31
라인
Merck to globally distribute T&R Biofab’s bio-ink
T&R Biofab said Wednesday that it has signed an original equipment manufact...
by Lee Han-soo  |  2018-08-22 12:30
라인
Lixiana faces patent challenge in substance, composition
Daiichi Sankyo’s anticoagulant treatment Lixiana (ingredient: edoxaban) has...
by Lee Hye-seon  |  2018-08-22 11:16
라인
Shire Korea gets approval for short bowel syndrome treatment
Rare disease specialty biopharmaceutical firm Shire Korea said Wednesday it...
by Marian Chu  |  2018-08-22 11:15
라인
Politician sponsors bill to honor medical professionals
A lawmaker is working to get medical workers who die in the midst of transp...
by Marian Chu  |  2018-08-21 18:12
라인
Pharma group will no longer provide souvenirs to medical workers
The Korea Research-based Pharma Industry Association (KRPIA) announced Tues...
by Lee Han-soo  |  2018-08-21 18:11
라인
Handok releases special medical food for Alzheimer’s
Handok said Tuesday that it has launched Souvenaid, a special medical food ...
by Lee Han-soo  |  2018-08-21 15:57
라인
Daiichi Sankyo publishes 1st RWD on Lixiana on Koreans
Daiichi Sankyo Korea published the first real-world data on Koreans for its...
by Marian Chu  |  2018-08-21 15:57
라인
[Special] Pharmaceuticals at odds with government over selective benefit system
The pharmaceutical industry is raising concerns over the government’s plan ...
by Nam Doo-hyun  |  2018-08-21 15:57
라인
Sanofi Pasteur, KSOC vaccinate S. Korean national squad for 2018 Asian Games
Korean athletes participating in the 2018 Asian Games in Jakarta and Palemb...
by Marian Chu  |  2018-08-21 11:50
라인
SNUBH, Macrogen to cooperate on precision medicine
SNUBH Vice President Baek Rong-min (right) and Macrogen CEO Yang Kap-seok h...
by Lee Han-soo  |  2018-08-21 11:50
여백
여백
여백
Back to Top